Prophylactic Antiplatelet Medication in Endovascular Treatment of Intracranial Aneurysms: Low-Dose Prasugrel versus Clopidogrel

References

1. 1.↵
   2. Molyneux A,
   3. Kerr R,
   4. Stratton I, et al

   . International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267–74 doi:10.1016/S0140-6736(02)11314-6 pmid:12414200

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Derdeyn CP,
   3. Cross DT 3rd.,
   4. Moran CJ, et al

   . Postprocedure ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils. J Neurosurg 2002;96:837–43 doi:10.3171/jns.2002.96.5.0837 pmid:12008697

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Ries T,
   3. Buhk JH,
   4. Kucinski T, et al

   . Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 2006;37:1816–21 doi:10.1161/01.STR.0000226933.44962.a6 pmid:16778126

   Abstract/FREE Full Text
4. 4.↵
   2. Yamada NK,
   3. Cross DT 3rd.,
   4. Pilgram TK, et al

   . Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007;28:1778–82 doi:10.3174/ajnr.A0641 pmid:17885244

   Abstract/FREE Full Text
5. 5.↵
   2. Hwang G,
   3. Jung C,
   4. Park SQ, et al

   . Thromboembolic complications of elective coil embolization of unruptured aneurysms: the effect of oral antiplatelet preparation on periprocedural thromboembolic complication. Neurosurgery 2010;67:743–48 doi:10.1227/01.NEU.0000374770.09140.FB pmid:20651627

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Kang HS,
   3. Han MH,
   4. Kwon BJ, et al

   . Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? Neurosurgery 2010;67:1371–76; discussion 1376 doi:10.1227/NEU.0b013e3181efe3ef pmid:20871459

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Rahme RJ,
   3. Zammar SG,
   4. El Ahmadieh TY, et al

   . The role of antiplatelet therapy in aneurysm coiling. Neurol Res 2014;36:383–88 doi:10.1179/1743132814Y.0000000317 pmid:24617939

   CrossRefPubMed
8. 8.↵
   CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329–39 doi:10.1016/S0140-6736(96)09457-3 pmid:8918275

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Yusuf S,
   3. Zhao F,
   4. Mehta SR, et al

   . Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494–502 doi:10.1056/NEJMoa010746 pmid:11519503

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Kang HS,
    3. Kwon BJ,
    4. Kim JE, et al

    . Preinterventional clopidogrel response variability for coil embolization of intracranial aneurysms: clinical implications. AJNR Am J Neuroradiol 2010;31:1206–10 doi:10.3174/ajnr.A2051 pmid:20223886

    Abstract/FREE Full Text
11. 11.↵
    2. Serebruany VL,
    3. Steinhubl SR,
    4. Berger PB, et al

    . Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246–51 doi:10.1016/j.jacc.2004.09.067 pmid:15653023

    CrossRefPubMed
12. 12.↵
    2. Delgado Almandoz JE,
    3. Kadkhodayan Y,
    4. Crandall BM, et al

    . Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms. J Neurointerv Surg 2014;6:767–73 doi:10.1136/neurintsurg-2013-010976 pmid:24353331

    Abstract/FREE Full Text
13. 13.↵
    2. Kim MS,
    3. Jo KI,
    4. Yeon JY, et al

    . Association between postprocedural infarction and antiplatelet drug resistance after coiling for unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2016;37:1099–105 doi:10.3174/ajnr.A4777 pmid:27056423

    Abstract/FREE Full Text
14. 14.↵
    2. Kim B,
    3. Kim K,
    4. Jeon P, et al

    . Thromboembolic complications in patients with clopidogrel resistance after coil embolization for unruptured intracranial aneurysms. AJNR Am J Neuroradiol 2014;35:1786–92 doi:10.3174/ajnr.A3955 pmid:24831597

    Abstract/FREE Full Text
15. 15.↵
    2. Asai T,
    3. Miyachi S,
    4. Izumi T, et al

    . Relationship between low response to clopidogrel and periprocedural ischemic events with coil embolization for intracranial aneurysms. J Neurointervent Surg 2016;8:752–55 doi:10.1136/neurintsurg-2015-011727 pmid:26109688

    Abstract/FREE Full Text
16. 16.↵
    2. Mega JL,
    3. Close SL,
    4. Wiviott SD, et al

    . Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009;119:2553–60 doi:10.1161/CIRCULATIONAHA.109.851949 pmid:19414633

    Abstract/FREE Full Text
17. 17.↵
    2. Gurbel PA,
    3. Bliden KP,
    4. Samara W, et al

    . Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. J Am Coll Cardiol 2005;46:1827–32 doi:10.1016/j.jacc.2005.07.056 pmid:16286166

    FREE Full Text
18. 18.↵
    2. Matetzky S,
    3. Shenkman B,
    4. Guetta V, et al

    . Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171–75 doi:10.1161/01.CIR.0000130846.46168.03 pmid:15184279

    Abstract/FREE Full Text
19. 19.↵
    2. Hochholzer W,
    3. Trenk D,
    4. Bestehorn HP, et al

    . Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 2006;48:1742–50 doi:10.1016/j.jacc.2006.06.065 pmid:17084243

    FREE Full Text
20. 20.↵
    2. Yang H,
    3. Li Y,
    4. Jiang Y, et al

    . Thromboelastography for monitoring platelet function in unruptured intracranial aneurysm patients undergoing stent placement. Interv Neuroradiol 2015;21:61–68 doi:10.15274/INR-2014-10094 pmid:25934777

    Abstract/FREE Full Text
21. 21.↵
    2. Yang H,
    3. Li Y,
    4. Jiang Y

    . Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement. J Neurosurg 2015 Nov 20. [Epub ahead of print] pmid:26587657

    CrossRefPubMed
22. 22.↵
    2. Hwang G,
    3. Huh W,
    4. Lee JS, et al

    . Standard vs modified antiplatelet preparation for preventing thromboembolic events in patients with high on-treatment platelet reactivity undergoing coil embolization for an unruptured intracranial aneurysm: a randomized clinical trial. JAMA Neurol 2015;72:764–72 doi:10.1001/jamaneurol.2015.0654 pmid:26010803

    CrossRefPubMed
23. 23.↵
    2. Wiviott SD,
    3. Antman EM,
    4. Braunwald E

    . Prasugrel. Circulation 2010;122:394–403 doi:10.1161/CIRCULATIONAHA.109.921502 pmid:20660815

    FREE Full Text
24. 24.↵
    2. Wiviott SD,
    3. Braunwald E,
    4. McCabe CH, et al

    . Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 2008;371:1353–63 doi:10.1016/S0140-6736(08)60422-5 pmid:18377975

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Wiviott SD,
    3. Braunwald E,
    4. McCabe CH, et al

    . Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001–15 doi:10.1056/NEJMoa0706482 pmid:17982182

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Sangkuhl K,
    3. Klein TE,
    4. Altman RB

    . Clopidogrel pathway. Pharmacogenet Genomics 2010;20:463–65 doi:10.1097/FPC.0b013e3283385420 pmid:20440227

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Cattaneo M

    . Fast, potent, and reliable inhibition of platelet aggregation. Eur Heart J Suppl 2009;11:G9–13 doi:10.1093/eurheartj/sup036

    Abstract/FREE Full Text
28. 28.↵
    2. Stetler WR,
    3. Chaudhary N,
    4. Thompson BG, et al

    . Prasugrel is effective and safe for neurointerventional procedures. J Neurointerv Surg 2013;5:332–36 doi:10.1136/neurintsurg-2012-010302 pmid:22619468

    Abstract/FREE Full Text
29. 29.↵
    2. Akbari SH,
    3. Reynolds MR,
    4. Kadkhodayan Y, et al

    . Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg 2013;5:337–43 doi:10.1136/neurintsurg-2012-010334 pmid:22555594

    Abstract/FREE Full Text